Article
|
Open Access
Featured
-
-
Article |
Safety and biodistribution of XC001 (encoberminogene rezmadenovec) gene therapy in rats: a potential therapy for cardiovascular diseases
- Duncan J. Stewart
- , Albert Gianchetti
- & Rickey R. Reinhardt
-
Article |
Homology-directed repair of an MYBPC3 gene mutation in a rat model of hypertrophic cardiomyopathy
- Jiali Nie
- , Yu Han
- & Dao Wen Wang
-
Article |
Effects of intracardiac delivery of aldehyde dehydrogenase 2 gene in myocardial salvage
- Guodong Pan
- , Bipradas Roy
- & Suresh Selvaraj Palaniyandi
-
Comment |
Micro-dystrophin gene constructs for repairing heart and muscle function in rats: the smaller is enough?
- Petra Lujza Szabo
- & Attila Kiss
-
Brief Communication |
Targeting mAKAPβ expression as a therapeutic approach for ischemic cardiomyopathy
- Eliana C. Martinez
- , Jinliang Li
- & Michael S. Kapiloff
-
Article
| Open Access
Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-DΔNΔC gene therapy eight-year follow-up of phase I KAT301 study
- Aleksi J. Leikas
- , Iiro Hassinen
- & Juha E. K. Hartikainen
-
Review Article
| Open Access
Genome editing for Duchenne muscular dystrophy: a glimpse of the future?
- Christian Kupatt
- , Alina Windisch
- & Maggie C. Walter
-
Review Article |
Gene therapy and gene correction: targets, progress, and challenges for treating human diseases
- Matthew R. Cring
- & Val C. Sheffield
-
Article
| Open Access
Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device – the SERCA-LVAD TRIAL
- A. R. Lyon
- , D. Babalis
- & S. E. Harding
-
Review Article |
Gene therapy for cardiovascular diseases in China: basic research
- Jiali Deng
- , Mengying Guo
- & Junjie Xiao
-
Article
| Open Access
AAV-mediated cardiac gene transfer of wild-type desmin in mouse models for recessive desminopathies
- T. Ruppert
- , M. B. Heckmann
- & O. J. Müller
-
Article |
MiR-140-5p inhibits oxidized low-density lipoprotein-induced oxidative stress and cell apoptosis via targeting toll-like receptor 4
- Huifang Liu
- , Ziming Mao
- & Fengling Chen
-
Comment |
AAV shedding after intracoronary delivery: just a safety concern?
- Kelly P. Yamada
- , Taro Kariya
- & Kiyotake Ishikawa
-
Article |
Estrogen administration reduces the risk of pulmonary arterial hypertension by modulating the miR-133a signaling pathways in rats
- Sijing Zhou
- , Ke Zhu
- & Ran Wang
-
Article |
Gene therapy for refractory angina and cell therapy for heart failure: experience of a Brazilian research group
- Roberto Tofani Sant’Anna
- , Bruna Eibel
- & Renato Abdala Karam Kalil
-
Original Article |
AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload
- D M Schwab
- , L Tilemann
- & O J Müller
-
Original Article |
Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis
- I Fishbein
- , D T Guerrero
- & R J Levy
-
Original Article |
Vascular endothelial growth factor-A gene electrotransfer promotes angiogenesis in a porcine model of cardiac ischemia
- A A Bulysheva
- , B Hargrave
- & R Heller
-
-
Original Article
| Open Access
AAV9-mediated gene transfer of desmin ameliorates cardiomyopathy in desmin-deficient mice
- M B Heckmann
- , R Bauer
- & O J Müller
-
Original Article |
Systemic injection of AAV9 carrying a periostin promoter targets gene expression to a myofibroblast-like lineage in mouse hearts after reperfused myocardial infarction
- B A Piras
- , Y Tian
- & B A French
-
Short Communication |
Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure
- B Greenberg
- , J Butler
- & K M Zsebo
-
Original Article |
Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells
- M Preis
- , J Schneiderman
- & M Y Flugelman
-
Original Article |
Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart
- M Merentie
- , L Lottonen-Raikaslehto
- & S Ylä-Herttuala
-
Original Article |
Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia
- M R Kibbe
- , A T Hirsch
- & E C Perin
-
Original Article |
Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction
- A S Fargnoli
- , M G Katz
- & C R Bridges
-
Original Article |
Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR−/− mice
- G Li
- , C Chen
- & S Li
-
-
Original Article |
Macrophage-specific overexpression of interleukin-5 attenuates atherosclerosis in LDL receptor-deficient mice
- W Zhao
- , T Lei
- & H Ou
-
Original Article |
Mesenchymal stromal cells overexpressing vascular endothelial growth factor in ovine myocardial infarction
- P Locatelli
- , F D Olea
- & A Crottogini
-
Original Article |
Permanent acceptance of mouse cardiac allografts with CD40 siRNA to induce regulatory myeloid cells by use of a novel polysaccharide siRNA delivery system
- Q Zhang
- , N Ichimaru
- & S Takahara
-
Original Article |
Prevention of hypoxic pulmonary hypertension by hypoxia-inducible expression of p27 in pulmonary artery smooth muscle cells
- Y Luo
- , B Zhang
- & Y-Q Gao
-
Original Article |
Deletion of CXCR4 in cardiomyocytes exacerbates cardiac dysfunction following isoproterenol administration
- E R Wang
- , A A Jarrah
- & S T Tarzami
-
Original Article |
Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure
- A H Chaanine
- , M Nonnenmacher
- & T Weber
-
Original Article
| Open Access
A macrophage-specific synthetic promoter for therapeutic application of adiponectin
- W S Kang
- , J S Kwon
- & Y Ahn
-
Original Article |
Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model
- C Weber
- , I Neacsu
- & S T Pleger
-
Original Article |
PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice
- E Leggiero
- , D Astone
- & L Pastore
-
Original Article
| Open Access
Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice
- S C Gordts
- , I Muthuramu
- & B De Geest
-
Original Article |
Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy
- A-M Lompré
- , L Hadri
- & L Lipskaia
-
Original Article |
Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery
- A B Katwal
- , P R Konkalmatt
- & B A French
-
Original Article |
Sequential, timely and controlled expression of hVEGF165 and Ang-1 effectively improves functional angiogenesis and cardiac function in vivo
- H Zhang
- , Y L Yuan
- & Z M Zhang
-
Original Article |
Intramyocardial transfer of hepatocyte growth factor as an adjunct to CABG: phase I clinical study
- J S Kim
- , H Y Hwang
- & K-B Kim
-
-
Review |
Sarcoplasmic reticulum and calcium cycling targeting by gene therapy
- J-S Hulot
- , G Senyei
- & R J Hajjar
-
-
-
Review |
Vein graft failure: current clinical practice and potential for gene therapeutics
- S Wan
- , S J George
- & A H Baker
-
-
Review |
VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond
- M Giacca
- & S Zacchigna
Ghrelin mediated cardioprotection using in vitro models of oxidative stress
Cardiac gene therapy: are we there yet?
Ultrasound-targeted microbubble destruction-mediated microRNA-21 transfection regulated PDCD4/NF-κB/TNF-α pathway to prevent coronary microembolization-induced cardiac dysfunction
SDF-1 in myocardial repair
Gene therapy for ventricular tachyarrhythmias
Prospects for gene transfer for clinical heart failure
Gene delivery technologies for cardiac applications